CEA Change After Neoadjuvant Chemotherapy Including Bevacizumab and Clinical Outcome in Patients Undergoing Liver Resection for Colorectal Liver Metastases
Crossref DOI link: https://doi.org/10.1245/s10434-014-4158-8
Published Online: 2014-10-17
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stremitzer, Stefan
Stift, Judith
Graf, Alexandra
Singh, Jagdeep
Starlinger, Patrick
Gruenberger, Birgit
Tamandl, Dietmar
Gruenberger, Thomas
Text and Data Mining valid from 2014-10-17